Address
Email address
Phone number
16. 04 kl 10.00 – 12.30 apteekrite, haiglate ja hulgimüüjate infotund. Infotundi saab vaadata SIIT 22.04 kell 13.00 Arendajate III töötuba (Teams kutse alusel) 26.04 algusega kell 21.00 EtMVS andmekogu ümberkolimine – süsteem ei ole kättesaadav Võltsravimite...
Name
Ravimite Ehtsuse Kontrolli Sihtasutus
Registry code
90013561
VAT number
EE101937331
Type
SA - Foundation
Status
Registered
Foundation date
26.10.2016 (8)
Financial year
01.01-31.12
Activity
63991 - Other information service activities n.e.c.
-
-
-
-
-
-
-
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Raul Mill
| - | Board member | - | |
Martin-Kaspar Sild
| - | - | - | Board member |
Tanel Kuusmann
| - | - | - | Board member |
Teet Torgo
| - | - | - | Board member |
Roland Lepik
| - | - | - | Board member |
Riho Tapfer
| - | - | - | Board member |
Marika Saar
| - | - | - | Board member |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q4 | 157 691.96 € | 34 982.95 € | 28 678.58 € | 2 |
2024 Q3 | 887 162.01 € | 48 016.73 € | 28 198.57 € | 2 |
2024 Q2 | 293 610.81 € | 41 656.73 € | 28 353.26 € | 1 |
2024 Q1 | 141 426.01 € | 31 820.02 € | 33 370.64 € | 1 |
2023 Q4 | 125 925.67 € | 22 928.67 € | 24 168.96 € | 1 |
2023 Q3 | 135 954.77 € | 22 656.83 € | 23 834.63 € | 1 |
2023 Q2 | 1 057 300.9 € | 63 611.36 € | 24 775.9 € | 2 |
2023 Q1 | 134 035.02 € | 33 364.04 € | 35 250.26 € | 2 |
2022 Q4 | 125 784.6 € | 24 988 € | 25 886.75 € | 1 |
2022 Q3 | 209 457 € | 22 638.04 € | 23 891.09 € | 2 |
2022 Q2 | 1 132 175.5 € | 81 616.32 € | 25 919.15 € | 2 |
2022 Q1 | 148 972.12 € | 31 237.11 € | 32 947.83 € | 2 |
2021 Q4 | 127 537 € | 18 387.17 € | 21 846.57 € | 3 |
2021 Q3 | 143 609 € | 19 287.25 € | 22 772.39 € | 3 |
2021 Q2 | 1 083 024.9 € | 69 898.65 € | 19 950.13 € | 3 |
2021 Q1 | 111 424.53 € | 23 651.3 € | 24 992.03 € | 3 |
2020 Q4 | 135 714.69 € | 18 254.56 € | 19 264.48 € | 3 |
2020 Q3 | 127 624 € | 18 630.84 € | 19 675.38 € | 3 |
2020 Q2 | 248 624 € | 19 551.45 € | 15 093.76 € | 3 |
2020 Q1 | 127 704.24 € | 20 441.06 € | 21 436.43 € | 3 |